Sky Century Investment (SKYI) Net Equity Issued and Repurchased (2013 - 2026)
Sky Century Investment (SKYI) posted quarterly Net Equity Issued and Repurchased of $85000.0 for Q2 2026, up 1488.79% quarter-over-quarter from $5350.0 in Q4 2013.
Sky Century Investment (SKYI) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $85000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $85000.0; the TTM figure through May 2026 stood at $85000.0 (changed N/A YoY), while the FY2025 annual figure was $29094.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased grew to $85000.0 in Q2 2026 per SKYI's latest filing, from $5350.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $85000.0 in Q2 2026 and bottomed at $85000.0 in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | 85,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 85,000.00 |
| May 31, 2026 | 85,000.00 |
| Nov 30, 2013 | 5,350.00 |
| Nov 30, 2013 | 5,350.00 |